Automated biological target volume delineation for radiotherapy treatment planning using FDG-PET/CT
暂无分享,去创建一个
Claus Belka | Maximilian Niyazi | Marcus Hacker | Ute Ganswindt | C. Belka | M. Niyazi | U. Ganswindt | M. Hacker | A. Elsner | F. Manapov | Farkhad Manapov | Sonja Landrock | Andreas Elsner | S. Landrock
[1] Karin Haustermans,et al. Is there a role for FGD-PET in radiotherapy planning in esophageal carcinoma? , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[2] C. Rübe,et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] Akram Al-Ibraheem,et al. Evidence for the use PET for radiation therapy planning in patients with cervical cancer: a systematic review. , 2011, Hematology/oncology and stem cell therapy.
[4] S. Marnitz,et al. Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy , 2006, Clinical Cancer Research.
[5] Cyrill Burger,et al. Automated functional image-guided radiation treatment planning for rectal cancer. , 2005, International journal of radiation oncology, biology, physics.
[6] F. Mottaghy,et al. Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without 18F-choline PET-CT detected simultaneous integrated boost , 2012, Radiation Oncology.
[7] Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome , 2011, Radiation oncology.
[8] K. Carson,et al. F-FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY / COMPUTED TOMOGRAPHY – BASED RADIOTHERAPY TARGET VOLUME DEFINITION IN NON – SMALL-CELL LUNG CANCER : DELINEATION BY RADIATION ONCOLOGISTS VS . JOINT OUTLINING WITH A PET RADIOLOGIST ? , 2022 .
[9] Robert Jeraj,et al. PET scans in radiotherapy planning of lung cancer. , 2012, Lung cancer.
[10] Daniela Thorwarth,et al. Physical radiotherapy treatment planning based on functional PET/CT data. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] C. Onal,et al. Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy , 2012, Radiation oncology.
[12] Giuseppe Lucio Cascini,et al. Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC). , 2007, Lung cancer.
[13] M. Hasegawa,et al. Phantom study on radiotherapy planning using PET/CT--delineation of GTV by evaluating SUV. , 2010, Journal of radiation research.
[14] Ronald Boellaard,et al. Impact of [18F]FDG PET imaging parameters on automatic tumour delineation: need for improved tumour delineation methodology , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[15] R. Wahl,et al. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.
[16] S. Macdonald,et al. PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: A case series , 2011, Radiation oncology.
[17] Mohamed Allaoua,et al. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. , 2004, International journal of radiation oncology, biology, physics.
[18] Johan Bussink,et al. PET–CT for radiotherapy treatment planning and response monitoring in solid tumors , 2011, Nature Reviews Clinical Oncology.
[19] B. Krause,et al. Curative treatment of oesophageal carcinoma: current options and future developments , 2011, Radiation oncology.
[20] Robert Jeraj,et al. Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive? , 2012, The Lancet. Oncology.
[21] C. Belka,et al. Choline PET based dose-painting in prostate cancer - Modelling of dose effects , 2010, Radiation oncology.
[22] D. Vriens,et al. Monitoring and Predicting Response to Therapy with 18F-FDG PET in Colorectal Cancer: A Systematic Review , 2009, Journal of Nuclear Medicine.
[23] David Binns,et al. A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] Kyung-Ja Cho,et al. FDG-PET in the prediction of pathologic response after neoadjuvant chemoradiotherapy in locally advanced, resectable esophageal cancer. , 2005, International journal of radiation oncology, biology, physics.
[25] Jean-François Daisne,et al. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. , 2004, Radiology.
[26] Hanna Bernstine,et al. Early prediction of histopathological response of rectal tumors after one week of preoperative radiochemotherapy using 18 F-FDG PET-CT imaging. A prospective clinical study , 2012, Radiation oncology.
[27] G. Stoffels,et al. Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas , 2012, Strahlentherapie und Onkologie.
[28] L. Gianolli,et al. PET-guided dose escalation tomotherapy in malignant pleural mesothelioma , 2011, Strahlentherapie und Onkologie.
[29] H. Zaidi,et al. Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma , 2012, Radiation oncology.
[30] Dirk De Ruysscher,et al. PET scans in radiotherapy planning of lung cancer. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[31] A. Scarsbrook,et al. [18F]FDG PET/CT imaging of colorectal cancer: a pictorial review , 2010, Postgraduate Medical Journal.
[32] D. Zips,et al. Bio-IGRT , 2010, Nuklearmedizin.
[33] M. Gregianin,et al. Tumour markers and FDG PET/CT for prediction of disease relapse in patients with breast cancer , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[34] Cyrill Burger,et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study. , 2003, International journal of radiation oncology, biology, physics.
[35] K Schnabel,et al. 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis. , 1999, International journal of radiation oncology, biology, physics.
[36] M. Thakur,et al. 18-Fluoro-Deoxy-Glucose Positron Emission Tomography With Computed Tomography–Based Gross Tumor Volume Estimation and Validation With Magnetic Resonance Imaging for Locally Advanced Cervical Cancers , 2012, International Journal of Gynecologic Cancer.
[37] F. Fazio,et al. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer. , 2005, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[38] Cordula Petersen,et al. [18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes , 2011, Radiation oncology.
[39] M. Dietlein,et al. Interpretation and validation of interim positron emission tomography in Hodgkin lymphoma , 2010, Leukemia & lymphoma.
[40] T. Hany,et al. 3D-Segmentation of the 18F-choline PET Signal for Target Volume Definition in Radiation Therapy of the Prostate , 2007, Technology in cancer research & treatment.
[41] D. de Ruysscher. PET-CT in radiotherapy for lung cancer. , 2011, Methods in molecular biology.